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Introduction
The idiopathic inflammatory myopathies (IIMs) are rare, chronic systemic connective tissue diseases characterized by infiltration of inflammatory cells at skeletal muscles and progressive muscle weakness. IIMs are heterogeneous group of disease known as dermatomyositis (DM), polymyositis (PM) and inclusion body myositis (IBM) (1, 2) . The muscle biopsy is an essential and definitive diagnostic modality for IIMs. The hallmark of the histological pathology is infiltration with inflammatory cells in the muscles. However, the inflammation of muscle may be unevenly distributed and not all of the muscles are affected at the same time. Even though persistent muscle weakness exists in some cases, the inflammatory infiltrate is only minimal or can no longer be found (3, 4) . Therefore, the selection technique for obtaining the appropriate sample should be used to guide for biopsy. And imaging tools can be particularly useful in identifying biopsy site (5, 6) . The signal intensity at STIR magnetic resonance imaging (MRI) of transaxial section. No signal intensity (arrowhead on Biceps femoris), subtle signal intensity (short narrow arrow on Semimembranous) were represented for score 0 and 1, respectively. Focal signal intensity (long narrow arrow on Vastus intermedialis) in each muscle which was affected less than 50% of area was represented for score 2. Diffuse signal intensity (wide arrow on Gracilis) was represented for score 3. are helpful to detect fatty degeneration of affected muscles (6, 7) . MRI can be used as guidance for biopsy in an area of active disease and thus may decrease the false-negative rate of 10-25% without imaging guidance (4, 8) . It can also assess the extent of lesions and monitoring therapeutic response in patients with IIMs has been reported previously (9) (10) (11) .
Especially, signal intensity (SI) in MRI is associated with disease activity in the acute presentation and after treatment of PM and DM. However, the use of MRI is not a standard practice.
In this study, we focused on the utility of MRI in the assessment of IIMs. The MRI findings were compared with other findings such as histopathologic, laboratory and clinical findings. Total 47 patients were identified location of biopsied muscle.
Materials and Methods

Patients
The most compartment of biopsy was anterior portion (78.7%), especially. Vastus lateralis was the dominant site for muscle biopsy among muscles of anterior compartment (n=30). In addition to muscle biopsies were taken at medial compartment (8.5%), gluteal muscles (8.5%), posterior compartment (2.1%) and tensor fascia lata (2.1%).
MRI findings and correlation with clinical findings and histopathologic scorings
Although two patients with DM asymmetrically affected in thigh MRI, almost patients showed symmetrically involved Total 38.3% of patients had myalgia (Table 1 ) and 78.3%
of patients with myalgia were DM. And total 43.3% of patients had fasciitis in MRI ( showed modest correlations with TSI (Table 3) . TSI was significantly increased in patients with decreased muscle power 
Discussion
There were no significant differences of demographic and laboratory findings between DM and PM patients except level of CK and aldolase in this study. These muscle enzymes could not be helpful to distinguish IIMs and to assess of disease activity because some patients had normal level of muscle enzymes and others have persistent elevated muscle enzyme without other signs of disease activity (13) . In this study, al- muscle biopsy was negative in 12.5% of cases (19) . To obtain a muscle biopsy to make a definitive diagnosis, the selection of an appropriate site is important. MRI can evaluate much larger area of muscle tissue than biopsy and procedure itself is less dependent on the operator compared with ultrasonography and other imaging studies (20, 21) . MRI also provides a non-invasive method of demonstrating subtle or subclinical changes unlike biopsy or EMG in individual muscles that cannot be isolated on strength testing (9, 11) . A muscle biopsy guided by positive MRI findings was contained more inflammatory cells than a biopsy taken from non-affected sites (11) . In this study, histophatological score showed positive correlation with edema and negative correlation with atrophy.
Therefore, the biopsy site should be chosen in the active area without atrophic change for accurate diagnosis.
Inflammatory muscle tissue of IIMs patients is edematous, though not specific for myositis. It may also be seen in injuries, infection, infarction and rhabdomyolysis et al.
However, the presence of muscle edema is not exclusive to IIMs and the increased signal intensity by edema is a typical finding in acute IIMs (22, 23) . In this study, TSI or SI on affected area rather than TAM showed correlations with muscle enzymes, muscle power and histopathologic grading. It could be suggested that the SI on MRI is more associated with clinical status of IIMs than affected extents. Some also reported that SI in the acute presentation of IIMs was associated with the disease activity, and improvement in MRI score could be a good parameter for short-term follow-up and clinical status assessment (11, 13) . Because of invasive nature, biopsy and EMG are not useful for follow-up and clinical status assessment. Therefore, SI on MRI can be used for assessment of disease activity and evaluation of effect for treatments.
There were some limitations in this study. Sample size was small and information of clinical assessments such as accurate muscle weakness, atrophy, muscle power and any other clin-ical symptoms was lack because of its nature of retrospective study. Biopsy might not be done in targeted sites through MRI, actually. And there might be some bias in the evaluation of inflammation because MRI and biopsied specimen were re-evaluated by one radiologist and one pathologist, respectively. There was no follow up study of MRI and biopsy after treatments for evaluating disease activity.
In summary, we evaluated the utility of MRI in patients with DM and PM. MRI can be more helpful for suspicious myopathy with normal muscle enzyme. The fasciitis in MRI also can be helpful in diagnosing DM, especially in early stage of DM. The biopsy should be taken at high affected muscle in MRI. The patients with decreased muscle power showed more increased total signal intensity than patients with normal power, and the signal intensity of MRI correlated with muscle enzymes and histopathologic grading. Therefore, the noninvasive nature and high sensitivity of muscle inflammation suggest that MRI should be considered prior to muscle biopsy and it can be used for assessment of disease activity during follow-up.
